Search - tctmd.com

Displaying 321 - 340 of 808

Sort: Relevancy | Date

News Daily News

FDA: Class I Recall for IntraClude Intra-Aortic Occlusion Device

Shelley Wood

July 02, 2019

News Daily News

Life Expectancy Post-SAVR Varies by Age, Raising Questions for Treatment Timing

Caitlin E. Cox

July 01, 2019

News Daily News

High Levels of Lp(a) Linked to Increased Ischemic Stroke Risk

Michael O'Riordan

July 01, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2019

Shelley Wood

June 28, 2019

News Daily News

New TAVR NCD a ‘Missed Opportunity’ to Align SAVR, TAVR Quality

Shelley Wood

June 27, 2019

News Daily News

Genetic Data Hint at Causal Link Between High BMI and Cardiovascular Diseases

Marcus A. Banks

June 24, 2019

News Daily News

CMS Releases Final Decision Memo on Rules for TAVR Program Reimbursement

Shelley Wood

June 24, 2019

News Industry News

Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation

June 24, 2019

News Conference News TVT 2019

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Michael O'Riordan

June 20, 2019

News Conference News TVT 2019

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Michael O'Riordan

June 19, 2019

News Industry News

CRF And VEITHsymposium Announce an Alliance Between Transcatheter Cardiovascular Therapeutics (TCT) and VEITHsymposium

June 19, 2019

News Conference News TVT 2019

Faster and Larger Gains in Physical Function With TAVR Than With Surgery: SURTAVI

Michael O'Riordan

June 17, 2019

News Daily News

TCAR Use Growing for Carotid Stenosis as Positive Data Continue to Accumulate

Todd Neale

June 17, 2019

News Conference News TVT 2019

Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry

Shelley Wood

June 17, 2019

Presentation TVT 2019

CroiValve Percutaneous Tricuspid Coaptation Valve

Presenter: Martin Quinn

June 15, 2019

Presentation TVT 2019

Successful BASILICA for a Failed CoreValve

Presenter: Ikki Komatsu

June 15, 2019

Presentation TVT 2019

Percutaneous Closure of an Acquired Aortic-Left Atrial Fistula

Presenter: Daniel Feldman

June 15, 2019

Presentation TVT 2019

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

Presenter: Torsten Vahl

June 15, 2019

Presentation TVT 2019

Functional Status After Transcatheter and Surgical Aortic Valve Replacement: A Two-Year Analysis From the SURTAVI Trial

Presenter: Mark Tuttle

June 15, 2019

News Conference News TVT 2019

Vast Numbers of Severe Symptomatic AS Patients Untreated? A Plea and Some Pushback

Shelley Wood

June 14, 2019

Advertisement

FDA: Class I Recall for IntraClude Intra-Aortic Occlusion Device

Life Expectancy Post-SAVR Varies by Age, Raising Questions for Treatment Timing

High Levels of Lp(a) Linked to Increased Ischemic Stroke Risk

TCTMD’s Top 10 Most Popular Stories for June 2019

New TAVR NCD a ‘Missed Opportunity’ to Align SAVR, TAVR Quality

Genetic Data Hint at Causal Link Between High BMI and Cardiovascular Diseases

CMS Releases Final Decision Memo on Rules for TAVR Program Reimbursement

Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

CRF And VEITHsymposium Announce an Alliance Between Transcatheter Cardiovascular Therapeutics (TCT) and VEITHsymposium

Faster and Larger Gains in Physical Function With TAVR Than With Surgery: SURTAVI

TCAR Use Growing for Carotid Stenosis as Positive Data Continue to Accumulate

Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry

CroiValve Percutaneous Tricuspid Coaptation Valve

Successful BASILICA for a Failed CoreValve

Percutaneous Closure of an Acquired Aortic-Left Atrial Fistula

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

Functional Status After Transcatheter and Surgical Aortic Valve Replacement: A Two-Year Analysis From the SURTAVI Trial

Vast Numbers of Severe Symptomatic AS Patients Untreated? A Plea and Some Pushback

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content